If you are looking for video content marketing tips, listen to what theatre-geek-turned-YouTube celebrity, Matthew Patrick (MatPat) has to say. Hard to believe the brain child of this 20-something, Game Theorists (his YouTube channel) has about 5 million subscribers and more than half billion views. Surprised, aren’t you?
With a degree in Neuroscience, MatPat dived into the musical theater stream. But the call of YouTube proved too strong and neuroscience couldn’t keep this young enthusiast away for too long. Making online videos was a major transition in his career, he remarks.
Though there’s a hell and heaven difference, but his passion for producing YouTube videos was fuelled by his experience in musical theater and his educational background of neuroscience.
Rome Wasn’t Built in a Day
Being a giant in You Tube didn’t happen overnight! “I started to become invested in the numbers, figuring out how I could tweak the system and tweak my videos to drive 10, 15, 20 percent more views,” Patrick says. “I learned how to get content shared in more suggested feeds and how to get my audiences to watch 10% longer … Over time I was able to get a sense not only of how users engage on the platform, but how YouTube’s algorithms work.”
Today he along with his team invests about 100 hours per week, with an output of 2 videos. In addition he also runs a consulting practice for helping bigger brands in using YouTube effectively.
Read more on how to hire a video production company.
Grab Them By Their Eyeballs
MatPat draws a thin line of separation between YouTube and TV viewers. He says YouTube viewers are quite impatient in compared to their TV counterparts. Until the video grabs their eyeballs and brain within the first few seconds, none of the viewers would stay there for a long time. Therefore, he says, it’s essential to create videos that appeal the very instant it is clicked upon.
Stick With The Winners, Collaborate With The Stars
There are different ways in which brands can benefit from the You Tubers. In one of the ways, they can sponsor a video or a series of videos on the channel. The strategy can be discussed between both the parties, depending on the requirement of the former and availability of the latter. In another way, the brand can endorse at the last few minutes of the video. This can propel the audience to know and respond to the brand in a much effective way.
Getting a good audience mass is a challenge for amateurs. Young brands would do better to collaborate established YouTuber stars that already have an audience. Savvy YouTubers stars can create great co-branded content that will reach audiences that a young brand doesn’t have yet.
Build Your Own Audience
If you have a strong audience and a good clientele base you can drive them in the direction that you want, be it in buying more of your products, or being spokespeople for your brand. The audience will be loyal if you consistently provide them with engaging content that they love. This will not only help you in building great audience base, it will also prove beneficial when it comes to monetizing the same.
Calm-PRT is a combination of ingredients designed to release stress and restore proper communication within the hypothalamic-pitui…
“The one book to read if you want to learn how to build powerful memory palaces, and other mnemonic tools.””How to Build Mnemonics…
Now updated: the definitive neuroscience resource―from Eric R. Kandel, MD (winner of the Nobel Prize in 2000); James H. Schwartz…
The Human Brain: Introduction, Primer, & Overview
Localization & Functional Neuroanatomy of the Brain
The ingredients in calm g promote healthy brain function by modulating glutamate signaling’ managing oxidative stress’ and promoti…
NEW YORK TIMES BESTSELLER The New York Times–bestselling author of The Brain That Changes Itself presents astounding advances i…
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/VJ0V35dX4tQA/info/
David E. Nichols, PhD
Abstract: This talk will provide a foundation for understanding the importance of 5-HT2A receptors in the brain, now widely believed to be the key brain target for psychedelics. The study of this G protein-coupled receptor (GPCR) has required research efforts across several disciplines. Although it was initially thought to couple only to Gq, leading to activation of phospholipase C, it is now known to couple to multiple intracellular signaling pathways. The unique psychopharmacological properties of psychedelics clearly demonstrate that this receptor has special importance as a critical component of sensory perception in humans, and by extension, may be a key player in mediating consciousness. This presentation will focus on current understanding of the structure-activity relationships of psychedelics at the 5-HT2A receptor from a molecular perspective that has included synthesis of libraries of compounds, in vitro effects on cloned wild-type and mutated receptors, in vivo studies in rats, and computational chemistry.
Until his retirement in June 2012, David E. Nichols, PhD, was the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology, and a Distinguished Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University. He also was an Adjunct Professor of Pharmacology and Toxicology at the Indiana University School of Medicine. He currently is an Adjunct Professor of Medicinal Chemistry at the University of North Carolina, Chapel Hill.
Nichols received his PhD from the University of Iowa in 1973, followed by a postdoctoral stint in Pharmacology. From his time as a graduate student, Nichols focused his research on the relationship between molecular structure and the action of substances that modify behavior. His research took him to Purdue University in 1974, where he remained until his retirement this year.
His research was funded by government agencies for more than three decades. Internationally recognized for his research on centrally active drugs, he is one of the world’s foremost authorities on psychedelic agents, and founded the nonprofit Heffter Research Institute in 1993. He also was a pioneer in the study of the medicinal chemistry of dopamine D1 receptor agonists, and in 1991 he and his colleagues first showed that dopamine D1 agonists had remarkable efficacy in a primate model of Parkinson’s disease. He consults for the pharmaceutical industry and has served on numerous committees and government review groups.
More videos available at http://psychedelicscience.org
At Psychedelic Science 2013, over 100 of the world’s leading researchers and more than 1,900 international attendees gathered to share recent findings on the benefits and risks of LSD, psilocybin, MDMA, ayahuasca, ibogaine, 2C-B, ketamine, DMT, marijuana, and more, over three days of conference presentations, and two days of pre- and post-conference workshops.
LSD Neuroscience – David E. Nichols